Cargando…

Molecular analysis of the AGXT gene in Syrian patients suspected with primary hyperoxaluria type 1

BACKGROUND: Characterization of the molecular basis of primary hyperoxaluria type 1 (PH-1) in Syria has been accomplished through the analysis of 90 unrelated chromosomes from 45 Syrians patients with PH-1 from different regions. METHODS: Alanine glyoxylate aminotransferase (AGXT) gene mutations hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Murad, Hossam, Alhalabi, Mohamad Baseel, Dabboul, Amir, Alfakseh, Nour, Nweder, Mohamad Sayah, Zghib, Youssef, Wannous, Hala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176596/
https://www.ncbi.nlm.nih.gov/pubmed/34082749
http://dx.doi.org/10.1186/s12920-021-00996-x
_version_ 1783703283577126912
author Murad, Hossam
Alhalabi, Mohamad Baseel
Dabboul, Amir
Alfakseh, Nour
Nweder, Mohamad Sayah
Zghib, Youssef
Wannous, Hala
author_facet Murad, Hossam
Alhalabi, Mohamad Baseel
Dabboul, Amir
Alfakseh, Nour
Nweder, Mohamad Sayah
Zghib, Youssef
Wannous, Hala
author_sort Murad, Hossam
collection PubMed
description BACKGROUND: Characterization of the molecular basis of primary hyperoxaluria type 1 (PH-1) in Syria has been accomplished through the analysis of 90 unrelated chromosomes from 45 Syrians patients with PH-1 from different regions. METHODS: Alanine glyoxylate aminotransferase (AGXT) gene mutations have been analyzed by using molecular detection methods based on the direct DNA sequencing for all exons of the AGXT gene. RESULTS: Seventeen pathogenic mutations were detected in our patients. Six mutations were novels. The three most frequent mutations were c.33_34insC (p.Lys12fs) in Exon 1, c.584 T < G; p.Met195Arg in exon 5 and c.1007 T > A (p.Val336Asp) in exon 10, with a frequency of 33.3%, 12.2%, and 11.1%, respectively. CONCLUSION: DNA sequencing used in this study can offer a useful method to investigate the mutations in Syrian PH-1 patients, and could offer an accurate tool for prenatal diagnosis and genetic counseling.
format Online
Article
Text
id pubmed-8176596
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81765962021-06-04 Molecular analysis of the AGXT gene in Syrian patients suspected with primary hyperoxaluria type 1 Murad, Hossam Alhalabi, Mohamad Baseel Dabboul, Amir Alfakseh, Nour Nweder, Mohamad Sayah Zghib, Youssef Wannous, Hala BMC Med Genomics Research BACKGROUND: Characterization of the molecular basis of primary hyperoxaluria type 1 (PH-1) in Syria has been accomplished through the analysis of 90 unrelated chromosomes from 45 Syrians patients with PH-1 from different regions. METHODS: Alanine glyoxylate aminotransferase (AGXT) gene mutations have been analyzed by using molecular detection methods based on the direct DNA sequencing for all exons of the AGXT gene. RESULTS: Seventeen pathogenic mutations were detected in our patients. Six mutations were novels. The three most frequent mutations were c.33_34insC (p.Lys12fs) in Exon 1, c.584 T < G; p.Met195Arg in exon 5 and c.1007 T > A (p.Val336Asp) in exon 10, with a frequency of 33.3%, 12.2%, and 11.1%, respectively. CONCLUSION: DNA sequencing used in this study can offer a useful method to investigate the mutations in Syrian PH-1 patients, and could offer an accurate tool for prenatal diagnosis and genetic counseling. BioMed Central 2021-06-03 /pmc/articles/PMC8176596/ /pubmed/34082749 http://dx.doi.org/10.1186/s12920-021-00996-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Murad, Hossam
Alhalabi, Mohamad Baseel
Dabboul, Amir
Alfakseh, Nour
Nweder, Mohamad Sayah
Zghib, Youssef
Wannous, Hala
Molecular analysis of the AGXT gene in Syrian patients suspected with primary hyperoxaluria type 1
title Molecular analysis of the AGXT gene in Syrian patients suspected with primary hyperoxaluria type 1
title_full Molecular analysis of the AGXT gene in Syrian patients suspected with primary hyperoxaluria type 1
title_fullStr Molecular analysis of the AGXT gene in Syrian patients suspected with primary hyperoxaluria type 1
title_full_unstemmed Molecular analysis of the AGXT gene in Syrian patients suspected with primary hyperoxaluria type 1
title_short Molecular analysis of the AGXT gene in Syrian patients suspected with primary hyperoxaluria type 1
title_sort molecular analysis of the agxt gene in syrian patients suspected with primary hyperoxaluria type 1
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176596/
https://www.ncbi.nlm.nih.gov/pubmed/34082749
http://dx.doi.org/10.1186/s12920-021-00996-x
work_keys_str_mv AT muradhossam molecularanalysisoftheagxtgeneinsyrianpatientssuspectedwithprimaryhyperoxaluriatype1
AT alhalabimohamadbaseel molecularanalysisoftheagxtgeneinsyrianpatientssuspectedwithprimaryhyperoxaluriatype1
AT dabboulamir molecularanalysisoftheagxtgeneinsyrianpatientssuspectedwithprimaryhyperoxaluriatype1
AT alfaksehnour molecularanalysisoftheagxtgeneinsyrianpatientssuspectedwithprimaryhyperoxaluriatype1
AT nwedermohamadsayah molecularanalysisoftheagxtgeneinsyrianpatientssuspectedwithprimaryhyperoxaluriatype1
AT zghibyoussef molecularanalysisoftheagxtgeneinsyrianpatientssuspectedwithprimaryhyperoxaluriatype1
AT wannoushala molecularanalysisoftheagxtgeneinsyrianpatientssuspectedwithprimaryhyperoxaluriatype1